International Journal of Nephrology and Renovascular Disease (Apr 2023)

Chronic Kidney Disease Management in the Middle East and Africa: Concerns, Challenges, and Novel Approaches

  • Al-Ghamdi S,
  • Abu-Alfa A,
  • Alotaibi T,
  • AlSaaidi A,
  • AlSuwaida A,
  • Arici M,
  • Ecder T,
  • El Koraie AF,
  • Ghnaimat M,
  • Hafez MH,
  • Hassan M,
  • Sqalli T

Journal volume & issue
Vol. Volume 16
pp. 103 – 112

Abstract

Read online

Saeed Al-Ghamdi,1 Ali Abu-Alfa,2 Turki Alotaibi,3 Ali AlSaaidi,4 Abdulkareem AlSuwaida,5 Mustafa Arici,6 Tevfik Ecder,7 Ahmed F El Koraie,8 Mohamed Ghnaimat,9 Mohamed H Hafez,10 Mohamed Hassan,11 Tarik Sqalli12 1Department of Medicine, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom Saudi of Arabia; 2Department of Nephrology and Hypertension, American University of Beirut, Beirut, Lebanon; 3Department of Transplant Nephrology, Hamed Al-Essa Organ Transplant Center, Kuwait City, Kuwait; 4Department of Nephrology, College of Medicine, University of Baghdad, Nephrology and Transplantation Center, Medical City Complex, Baghdad, Iraq; 5Department of Medicine, King Saud University, Riyadh, Saudi Arabia; 6Department of Nephrology, Hacettepe University Faculty of Medicine, Ankara, Turkey; 7Department of Nephrology, Demiroglu Bilim University Faculty of Medicine, Istanbul, Turkey; 8Department of Internal Medicine and Nephrology, Alexandria Faculty of Medicine, Alexandria, Egypt; 9Department of Nephrology Specialty Hospital, Amman, Jordan; 10Department of Nephrology and Medicine, Cairo University, Cairo, Egypt; 11Department of Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates; 12Department of Nephrology, Moroccan Society of Nephrology, Casablanca, MoroccoCorrespondence: Mohamed Hassan, Department of Medical Affairs, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates, Tel +971 508187944, Email [email protected]: The burden of chronic kidney disease (CKD) and other comorbidities, such as hypertension and diabetes, which increase the risk of developing CKD, is on the rise in the Middle East and Africa. The Middle East and Africa CKD (MEA-CKD) steering committee, comprising eminent healthcare specialists from the Middle East and Africa, was formed to identify and propose steps to address the gaps in the management of CKD in these regions. The current article lists the MEA-CKD steering committee meeting outcomes and evaluates the available evidence supporting the role of novel therapeutic options for patients with CKD. The need of the hour is to address the gaps in awareness and screening, early diagnosis, along with referral and management of patients at risk. Measures to bring about appropriate changes in healthcare policies to ensure access to all benefit-proven protective therapies, including novel ones, at community levels are also vital for reducing the overall burden of CKD on the healthcare system as well as governing bodies, especially in developing countries of the Middle East and Africa.Keywords: chronic kidney disease, Middle East and Africa, CKD management, CKD management gaps, CKD concerns, novel therapies

Keywords